BioMotiv
Accelerating Breakthrough Discoveries into Medicines

News

News

BioMotiv Announces CEO Transition

BioMotiv announced today that Baiju R. Shah will step down from his role as CEO, and Ted Torphy, PhD, BioMotiv’s Chief Scientific Officer, has been selected to serve as BioMotiv’s CEO during the transition while also continuing to serve as the company’s CSO.

Read More
Erin Reese
Harrington Discovery Institute at University Hospitals Announces 2019 Grant Funding to 10 Physician-scientists

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2019 Harrington Scholar-Innovator Award recipients. The projects supported by the awards include new therapeutics to treat metabolic disorders, autoimmune disorders and cancer, and new approaches to eradicate parasitic diseases in developing countries.

Read More
Erin Reese
BioMotiv & PharmaLex Establish Preferred Partnership

PharmaLex Group, one of the largest and most successful specialist providers of Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance, Epidemiology and Risk Management worldwide, has entered into a preferred partnership with BioMotiv, a mission-driven accelerator that advances breakthrough discoveries from research institutions into therapeutics for patients.

Read More
Erin Reese